TrialEuropean urology focus2018

Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer.

Robert S Svatek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.